Treatment and Complication of Bath PUVA in Vitiligo

The recruitment status of this study is unknown because the information has not been verified recently.

Verified January 2008 by Shahid Beheshti University of Medical Sciences.
Recruitment status was Recruiting

Sponsor:

Information provided by:

Shahid Beheshti University of Medical Sciences

ClinicalTrials.gov Identifier:

NCT00380471

First received: September 25, 2006

Last updated: January 22, 2008

Last verified: January 2008

History of Changes

Purpose

The purpose of this study is to determine whether bath PUVA are effective in treatment of vitiligo and what is the complication of bath PUVA in vitiligo.

Condition	Intervention	Phase
Vitiligo	Device: Bath PUVA	Phase 2


Study Type:	Interventional
Study Design:	Allocation: Non-Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Single Blind Primary Purpose: Treatment
Official Title:	Treatment and Complication of Bath PUVA in Vitiligo

Resource links provided by NLM:

Genetics Home Reference related topics: vitiligo

MedlinePlus related topics: Vitiligo

Genetic and Rare Diseases Information Center resources: Hypomelanotic Disorder

U.S. FDA Resources

Further study details as provided by Shahid Beheshti University of Medical Sciences:


Study Start Date:	January 2006
Estimated Study Completion Date:	August 2006

Eligibility


Ages Eligible for Study:	18 Years to 70 Years (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Vitiligo

Exclusion Criteria:

Pregnancy

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00380471

Contacts


Contact: Parviz Toossi, M.D.	98-21-22744392 ext 5	src@sbmu.ac.ir

Locations


Iran, Islamic Republic of
Skin Research Center, Shaheed Beheshti Medical University	Recruiting
Tehran, Iran, Islamic Republic of, 19899
Contact: Parviz Toossi, M.D. 98-21-22744392 src@sbmu.ac.ir
Principal Investigator: Parviz Toossi, M.D.
Sub-Investigator: Fatemeh Aryanejad, MD
Sub-Investigator: Gita Meshkat Razavi, MD

Sponsors and Collaborators

Shahid Beheshti University of Medical Sciences

Investigators


Study Chair:	Parviz Toossi, M.D.	Shahid Beheshti University of Medical Sciences

More Information


ClinicalTrials.gov Identifier:	NCT00380471 History of Changes
Other Study ID Numbers:	src-pts-968
Study First Received:	September 25, 2006
Last Updated:	January 22, 2008
Health Authority:	Iran: Ethics Committee

Keywords provided by Shahid Beheshti University of Medical Sciences:


bath PUVA

Additional relevant MeSH terms:


Vitiligo Hypopigmentation Pigmentation Disorders Skin Diseases

ClinicalTrials.gov processed this record on September 30, 2016

To Top